Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialLy‐Mee Yu, Richard Hobbs, Monique Andersson et al.|The Lancet|2021Cited by 310